Yuval Horn Co Chaired the IBA 6th M&A in the Tech Sector Conference on March 23-24, 2023.
March 25, 2023
Tal Gazanda represented ART MEDICAL in a strategic collaboration agreement with Teva Pharmaceuticals (TEVA).
March 19, 2023
Yuval Horn, Paz Abercohen, Ana Eiskov, Shiran Glantz and Shai Perel represent VBL in the merger with Notable.
February 23, 2023
Yuval Horn, Shimrit Roznek, Yael Bar Hillel and Taisia Kris represent VBL in the Agreement to Sell the Manufacturing Facility and Certain Related Assets for $7.1 Million.
February 23, 2023
Yuval Horn, Keren Kanir, Yonatan Levinstein and Dorin Cohn Arbel represented Immunorizon on the acquisition by Purple Biotech (NASDAQ/TASE: PPBT) in consideration for up to $100 million.
February 6, 2023
Shimrit Roznek Co-Chaired the IBA 5th Silicon Beach Conference on January 21-24, 2023
January 25, 2023
Yuval Horn, Assaf Unger and Ana Eiskov represented The INX Digital Company, Inc. in a joint venture with SICPA SA in the field of central bank digital currencies.
December 22, 2022
Uri Dotan and Shiran Glantz represent Pangea in its seed investment round
December 16, 2022
Yuval Horn & Shimrit Roznek represented Kamari Pharma in a Joint Venture Agreement raising 8 Million USD.
September 19, 2022
Yuval Horn, Yonatan Levinstein and Tal Gazanda represented Prisma Photonics in a strategic investment agreement with Israel Natural Gas Lines (INGL). Mazal tov to Eran Inbar and the team on this great vote of confidence!
August 2, 2022
